![Philip Chase](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Chase
Director Ejecutivo en
Adimab LLC
.
Perfil
Philip T.
Chase is Chief Executive Officer at Adimab LLC since 2022.
Former roles include Director at Invivyd, Inc., Vice President & General Counsel at EPIX Pharmaceuticals, Inc., Chief Corporate Counsel at Transkaryotic Therapies, Inc., Vice President & General Counsel at RenaMed Biologics, Inc., and Vice President-Legal Affairs at Alnylam Pharmaceuticals, Inc. Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at Colby College.
Cargos activos de Philip Chase
| Empresas | Cargo | Inicio |
|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Director Ejecutivo | 01/04/2022 |
Antiguos cargos conocidos de Philip Chase.
| Empresas | Cargo | Fin |
|---|---|---|
| INVIVYD, INC. | Director/Miembro de la Junta | - |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Consejero General | - |
| ALNYLAM PHARMACEUTICALS, INC. | Consejero General | - |
RenaMed Biologics, Inc.
 RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | Consejero General | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Consejero General | - |
Formación de Philip Chase.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
9
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | Health Services |
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Operates as a biologics discovery and engineering company that develops antibody drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
- Bolsa de valores
- Insiders
- Philip Chase
